Lantern Pharma (LTRN) Receivables - Other (2019 - 2020)
Lantern Pharma's (LTRN) quarterly Receivables - Other came in at $11000.0 in Q4 2020, little changed YoY from $11000.0 in Q1 2020, and little changed on a QoQ basis from $11000.0 in Q3 2020.
Lantern Pharma (LTRN) Receivables - Other (2019 - 2020) Analysis & Trends
Lantern Pharma (LTRN) has 2 years of Receivables - Other data on file, last reported at $11000.0 in Q4 2020.
- Quarterly Receivables - Other changed 0.0% year-over-year to $11000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $11000.0 (changed 0.0% YoY) and the FY2020 annual result came in at $11000.0, changed 0.0% from the prior year.
- Receivables - Other steadied at $11000.0 in Q4 2020, from $11000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $11000.0 in Q4 2019 to a low of $11000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Lantern Pharma | 26.11 Mn | 26.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 11,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |